血清晚期糖基化终末产物肽水平在维吾尔族人群(3)
【作者】网站采编
【关键词】
【摘要】本文无利益冲突。 [1]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4)::10./ Diabetes for the preventi
本文无利益冲突。
[1]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4)::10./ Diabetes for the prevention and control of type 2 diabetes in China (2017 edition)[J].Chin J Pract Intern Med,2018,38(4)::10./j.nk.
[2]李熙建,王福莲,泽拥吉,等.糖化血红蛋白与胰岛功能水平变化在糖尿病中的应用[J].国际检验医学杂志,2019,40(20)::10.3969/ X J,WANG F L,ZE Y J,et of changes of glycosylated hemoglobin and islet function in diabetes mellitus[J].Int J Lab Med,2019,40(20)::10.3969/
[3]刘宇翔,郭海健,汪清,等.指尖血糖在社区筛查糖尿病及前期人群中应用价值的研究[J].中国糖尿病杂志,2019,27(1):7-10.DOI:10.3969/ Y X,GUO H J,WANG Q,et al.Value of fingertip glucose in diabetes and prediabetes screening in community[J].Chin J Diabetes,2019,27(1):7-10.DOI:10.3969/
[4]廖世波,黄淑玉,邹毅,等.初诊2型糖尿病患者75g葡萄糖负荷后血糖升高速率的影响因素研究[J].中国全科医学,2020,23(25)::10./ S B,HUANG S Y,ZOU Y,et factors of blood glucose elevation rate after 75 g glucose load in newly diagnosed type 2 diabetic patients[J].Chin Gen Pract,2020,23(25)::10./
[5]刘冰,洪旭.血尿酸水平与初诊2型糖尿病患者游离脂肪酸及糖基化终末产物的相关性分析[J].中国实验诊断学,2018,22(5)::10.3969/ B,HONG between serum uric acid level and free fatty acid,glycation end products in patients with newly diagnosed type 2 diabetes[J].Chin J Lab Diagn,2018,22(5)::10.3969/
[6]王星星,郭龙华,吕云.2型糖尿病合并症的生化指标社区预警筛查[J].中国病案,2020,21(1):104-107.
[7]夏琳,石茂翔,黎安玲.糖尿病患者尿糖水平与尿白细胞干化学及尿液炎性细胞因子的相关性研究[J].临床血液学杂志:输血与检验版,2016,29(5)::10./ L,SHI M X,LI A between urine glucose level and urine leukocytes count and inflammatory factors in patients with diabetes mellitus[J].J Clin Hematol:Blood Transfus Lab Med Ed,2016,29(5)::10./
[8]KOWALL B,RATHMANN W,BONGAERTS B,et rates of type 2 diabetes in people with impaired fasting glucose (ADA vs.WHO criteria) and impaired glucose tolerance:results from an older population (KORA S4/F4/FF4 study)[J].Diabetes Care,2019,42(2)::10.2337/dc18-1473.
[9]SUN Z,HE J,QIU S,et al.Using serum advanced glycation end products-peptides to improve the efficacy of World Health Organization fasting plasma glucose criterion in screening for diabetes in high-risk Chinese subjects[J].PLoS One,2015,10(9):e0.DOI:10.1371/
[10]DALLAK M,HAIDARA M A,BIN-JALIAH I,et suppresses aortic ultrastrucural damage and hypertension induced by diabetes:a potential role of advanced glycation end products[J].Ultrastruct Pathol,2019,43(4/5)::10.1080/0.2019..
[11]MORI H,KURODA A,ISHIZU M,et of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes[J].J Diabetes Investig,2019,10(5)::10.1111/jdi..
[12]MARUF M H,SUZUKI A,HAYASHI K,et advanced glycation end products in hypertrophied ligamentum flavum of diabetes mellitus patients[J].Spine J,2019,19(10)::10.1016/
[13]许娟,姜天,夏莉,等.皮肤晚期糖基化终产物无创检测技术在社区糖尿病早期筛查中的应用价值[J].中华糖尿病杂志,2020,12(4)::10.3760/ J,JIANG T,XIA L,et of skin advanced glycosylation end products:a non-invasive detection technology in early screening of community diabetes mellitus[J].Chin J Diabetes Mellit,2020,12(4)::10.3760/
[14]BABTAN A M,ILEA A,BOSCA B A,et glycation end products as biomarkers in systemic diseases:premises and perspectives of salivary advanced glycation end products[J].Biomark Med,2019,13(6)::10.2217/bmm-2018-0448.
文章来源:《实用糖尿病杂志》 网址: http://www.sytnbzz.cn/qikandaodu/2021/0611/1340.html